Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Under evaluation Remove Under evaluation filter

Referral safety status

Yes (2) Apply Yes filter

Referral type

Article 20 procedures Remove Article 20 procedures filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 30 referrals Remove Article 30 referrals filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 31 referrals (10) Apply Article 31 referrals filter Article 107i procedures (4) Apply Article 107i procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (12) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (12) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures Remove Risk minimisation measures filter No further action (1) Apply No further action filter Suspension (3) Apply Suspension filter Variation (2) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (1) Apply Accelerated assessment filter Additional monitoring (8) Apply Additional monitoring filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

12 results

Remove all filtersRemove all filters

Keyword Remove keyword

Medicine Referrals Remove Referrals filter

Referral status European Commission final decision Remove European Commission final decision filter Under evaluation Remove Under evaluation filter

Referral type Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 30 referrals Remove Article 30 referrals filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 20 procedures Remove Article 20 procedures filter

Categories Human Remove Human filter

Referral PRAC recommendation Risk minimisation measures Remove Risk minimisation measures filter

Sort by

List item

Referral: Corlentor and Procoralan

ivabradine, associated names: Corlentor and Procoralan, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 15/01/2015, Last updated: 16/02/2015
List item

Referral: Zydelig

idelalisib, associated names: Zydelig, Article 20 procedures
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 15/09/2016, Last updated: 03/10/2016
List item

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

daclatasvir, dasabuvir, sofosbuvir, ledipasvir, simeprevir, ombitasvir, paritaprevir, ritonavir, associated names: Sovaldi, Olysio, Viekirax, Harvoni, Exviera, Daklinza, Article 20 procedures
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 23/02/2017, Last updated: 09/03/2017
List item

Referral: Esmya

ulipristal acetate, associated names: Esmya, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/05/2018, EC decision date: 26/07/2018, Last updated: 08/08/2018
List item

Referral: Xofigo

radium Ra223 dichloride, associated names: Xofigo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 26/07/2018, EC decision date: 28/09/2018, Last updated: 11/10/2018
List item

Referral: Zinbryta

daclizumab, associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, opinion/position date: 09/11/2017, EC decision date: 08/01/2018, Last updated: 12/01/2018
List item

Referral: Iclusig

ponatinib, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 15/01/2015, Last updated: 02/03/2015
List item

Referral: Lemtrada

alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020
List item

Referral: Xeljanz

tofacitinib, associated names: Xeljanz, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 31/01/2020, Last updated: 06/03/2020
List item

Referral: Tysabri

natalizumab, associated names: Tysabri, Article 20 procedures
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 25/04/2016, Last updated: 12/05/2016
List item

Referral: SGLT2 inhibitors (previously canagliflozin)

canagliflozin, empagliflozin, dapagliflozin, metformin, associated names: Xigduo, Ebymect, Edistride, Synjardy, Forxiga, Jardiance, Vokanamet, Invokana, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 04/05/2017, Last updated: 08/05/2017
List item

Referral: SGLT2 inhibitors

canagliflozin, dapagliflozin, empagliflozin, associated names: Edistride, Ebymect, Xigduo, Vokanamet, Synjardy, Jardiance, Invokana, Forxiga, Article 20 procedures
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 18/05/2016

12 results

Referral: Corlentor and Procoralan

Referral: Zydelig

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

Referral: Esmya

Referral: Xofigo

Referral: Zinbryta

Referral: Iclusig

Referral: Lemtrada

Referral: Xeljanz

Referral: Tysabri

Referral: SGLT2 inhibitors (previously canagliflozin)

Referral: SGLT2 inhibitors